Search Page

1

Cite

Share

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN. Terry J, et al. Among authors: leung s. Am J Surg Pathol. 2010 Dec;34(12):1805-11. doi: 10.1097/PAS.0b013e3181f7dae3. Am J Surg Pathol. 2010. PMID: 21107086

Cite

Share

2

Cite

Share

Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.

Ionescu DN, Treaba D, Gilks CB, Leung S, Renouf D, Laskin J, Wood-Baker R, Gown AM. Ionescu DN, et al. Among authors: leung s. Am J Surg Pathol. 2007 Jan;31(1):26-32. doi: 10.1097/01.pas.0000213319.04919.97. Am J Surg Pathol. 2007. PMID: 17197916

Cite

Share

3

Cite

Share

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers.

Rajput AB, Miller MA, De Luca A, Boyd N, Leung S, Hurtado-Coll A, Fazli L, Jones EC, Palmer JB, Gleave ME, Cox ME, Huntsman DG. Rajput AB, et al. Among authors: leung s. J Clin Pathol. 2007 Nov;60(11):1238-43. doi: 10.1136/jcp.2006.043810. Epub 2007 Jan 26. J Clin Pathol. 2007. PMID: 17259299 Free PMC article.

Cite

Share

4

Cite

Share

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.

Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, McKinney S, Treaba DO, Boyd N, Goldstein LC, Badve S, Gown AM, van de Rijn M, Nielsen TO, Gilks CB, Huntsman DG. Turbin DA, et al. Among authors: leung s. Breast Cancer Res Treat. 2008 Aug;110(3):417-26. doi: 10.1007/s10549-007-9736-z. Epub 2007 Oct 3. Breast Cancer Res Treat. 2008. PMID: 17912629

Cite

Share

5

Cite

Share

Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.

Crabb SJ, Bajdik CD, Leung S, Speers CH, Kennecke H, Huntsman DG, Gelmon KA. Crabb SJ, et al. Among authors: leung s. Breast Cancer Res. 2008;10(1):R6. doi: 10.1186/bcr1847. Epub 2008 Jan 14. Breast Cancer Res. 2008. PMID: 18194560 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Cheang MC, et al. Among authors: leung s. Clin Cancer Res. 2008 Mar 1;14(5):1368-76. doi: 10.1158/1078-0432.CCR-07-1658. Clin Cancer Res. 2008. PMID: 18316557

Cite

Share

7

Cite

Share

Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.

Han G, Gilks CB, Leung S, Ewanowich CA, Irving JA, Longacre TA, Soslow RA. Han G, et al. Among authors: leung s. Am J Surg Pathol. 2008 Jul;32(7):955-64. doi: 10.1097/PAS.0b013e318164edf7. Am J Surg Pathol. 2008. PMID: 18460981

Cite

Share

8

Cite

Share

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

Crabb SJ, Cheang MC, Leung S, Immonen T, Nielsen TO, Huntsman DD, Bajdik CD, Chia SK. Crabb SJ, et al. Among authors: leung s. Clin Breast Cancer. 2008 Jun;8(3):249-56. doi: 10.3816/CBC.2008.n.028. Clin Breast Cancer. 2008. PMID: 18650155

Cite

Share

9

Cite

Share

Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.

Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, Chan SK, Jones SJ, Leung SP, Masoudi H, Leung S, Wiseman SM, Nabi IR. Joshi B, et al. Among authors: leung sp, leung s. Cancer Res. 2008 Oct 15;68(20):8210-20. doi: 10.1158/0008-5472.CAN-08-0343. Cancer Res. 2008. PMID: 18922892

Cite

Share

10

Cite

Share

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Habibi G, Leung S, Law JH, Gelmon K, Masoudi H, Turbin D, Pollak M, Nielsen TO, Huntsman D, Dunn SE. Habibi G, et al. Among authors: leung s. Breast Cancer Res. 2008;10(5):R86. doi: 10.1186/bcr2156. Epub 2008 Oct 16. Breast Cancer Res. 2008. PMID: 18925950 Free PMC article.

Cite

Share